Advanced Cardiovascular Systems, Inc. develops and manufactures cardiovascular medical products. It operates as a subsidiary of Abbott Laboratories. Its medical devices help patients with heart diseases in returning to active and productive lives and physicians for improving patient management and clinical outcomes. Advanced Cardiovascular Systems, Inc. is based in Santa Clara, California. it is currently known as Abbott Cardiovascular Systems.

Pulse Therapeutics is a growing medical technology company headquartered in St. Louis, Mo. The medical developer is advancing the fight against stroke, heart disease, and other conditions with its high-level treatment solutions, which utilize the latest biomedical technology and processes. Pulse’s signature offering, the MED System, was designed to harness magnet-based technology to rapidly dissolve blood clots faster than current modalities. This faster rate of delivery of FDA-approved clot-busting medication could dramatically reduce the number of lives lost each year to stroke, heart disease, and other diseases. This pioneering medical development company was founded by leading physicists Francis “Duke” Creighton and Rogers Ritter. Dr. Creighton, who also serves as Pulse’s chief technical officer, has 20-plus years of expertise in the medical technology industry, specializing in the stroke and cardiovascular sectors. He responsible for 30 patents and is a technology reviewer for the National Cancer Institute, National Science Foundation, and National Institutes of Health. The ground-breaking medical solutions of Pulse Therapeutics continues to attract investors and garner media coverage.

Medtronic Vascular designs and develops technologies for coronary, peripheral, and neurovascular indications. The company’s products include S7 Zipper MX Coronary Stent System, Clo-Sur PAD Nonwoven Hydrophilic Wound Dressing, Launcher Coronary Guide Catheter, and Stormer Over-the-Wire Balloon Dilatation Catheter. The company also offers Bridge Assurant Balloon-Expandable Stent Delivery System, GuardWire Plus Temporary Occlusion and Aspiration System, and S660 Coronary Stent. Medtronic Vascular was incorporated in 1991 and is based in Santa Rosa, California. As of January 29, 1999, Medtronic Vascular operates as a subsidiary of Medtronic.

CVPath Institute is an educational and research institute that works to improve the health of cardiac and vascular patients.

LuMend, Inc. used to develop medical devices. It delivered technology and services to interventional cardiologists, radiologists and vascular surgeons specializing in endovascular techniques for the treatment of peripheral vascular diseases. The company also provided a clinical solution to chronic total occlusions. LuMend was founded by John B. Simpson & Matthew R. Selmon in 1996 and was headquartered in Redwood City, CA.

Radiation Monitoring Devices (RMD) is the research business unit of Dynasil Corporation of America. Since 1974 RMD has been a world leader in providing innovative solutions across a broad range of security, medical and industrial applications, including radiation imaging and detection, nuclear instrumentation and non-destructive test equipment. RMD has technology practices in material science, radiation detection, digital imaging technology, magnetic imaging, laser optics and photonics.

Unity Biotechnology, Inc. operates as a biotechnology company. The firm is developing a portfolio of programs like biological mechanisms implicated in diseases of aging, and also senolytic programs in ophthalmologic and neurologic disorders. The company was founded by Nathaniel Eames David, Jan van Deursen, Judith Campisi, and Daohong Zhou on March 30, 2009 and is headquartered in South San Francisco, CA.

The Buck Institute is the nation’s first independent research facility focused solely on understanding the connection between aging and chronic disease. Their mission is to increase the healthy years of life. At the Buck Institute, world-class scientists work in a uniquely collaborative environment to understand how normal aging contributes to the development of conditions specifically associated with getting older such as Alzheimer’s and Parkinson’s diseases, cancer, stroke, osteoporosis, heart disease, diabetes, macular degeneration and glaucoma. Their interdisciplinary approach brings scientists from disparate fields together to develop diagnostic tests and treatments to prevent or delay these maladies. The stakes have never been higher. While it’s true that people are living longer, those “extra” years are often marked by disability and pain. In addition to personal hardship, there is also a cost to society. The financial burden of treating the chronic diseases of aging is expected to rise steadily as Baby Boomers get older. There is an urgency to Their mission.

Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert in 1950 and headquartered in Irvine, CA.

Columbia University provides a hub for entrepreneurship-related information and programming.

Pulse Medical Imaging Technology Shanghai Co. Ltd. is a Chinese company specializing in commercial physical and biological research.

The 301 Hospital (Chinese: 三〇一医院) or People's Liberation Army General Hospital (Chinese: 中国人民解放军总医院), which constitutes simultaneously the PLA Postgraduate Medical School (Chinese: 中国人民解放军医学院), located in Beijing, China, is a military hospital directly subsidiary to Logistic Support Department of the Central Military Commission and the largest general hospital under the auspices of the People's Liberation Army. Its mission includes assuring the health of PLA and China's leaders.

Guangdong Norco Cooling and Heating Equipment Co., Ltd., established on 1995-12-19, Business scope includes research and development,manufacture,Sales:Gas wall-hung furnace,Gas heating water heater,gas boiler,Condensing gas heating bath dual-purpose furnace,gas water heater,Clothes care machine,dishwasher,gas cooker,water heater,heat exchanger,water pump,fan,heat pump,heating appliances,Fresh air equipment,Plumbing,rice cooker,electric kettle,Electronic tile,Evaporator,Gas wall-hung boiler spare parts,dry,ventilation,air conditioner(Including heating and cooling equipment);Company product installation and commissioning and after-sales service;real estate development,operate.(The above projects do not involve special management measures for foreign investment access)(multiple photos)(One Photo Multiple Addresses)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Pharmasonics develops, manufactures and plans to market power ultrasonic interventional cardiology devices to address the problem of restenosis in coronary arteries. Their lead product aims to reduce the rate of restenosis after intervention by applying a therapeutic level of ultrasound radiation to the target lesion

Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA.

Ningbo Chuangdao 3D Medical Technology Co., Ltd., established on 2015-01-28, The scope of business includes the first category,second category,Class III medical devices,Composite molding equipment,printer,Industrial robot,computer,Development of software and auxiliary equipment,manufacture,Sales and technical service;teaching instrument,Teaching Models and Teaching Aids,Research and development of testing machine,manufacture,Sales,Technical service and leasing;Daily and medical plastic products and rubber products,other rubber products,Hydrogels,lubricant,Research and development of metal products,manufacture,Sales;sales of cosmetics.Self-operated and agent import and export of various goods and technologies,Except for goods and technologies that are restricted by the state or prohibited from import and export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Fu Wai Hospital, founded in 1956.

Elucid Bioimaging, Inc. is a company headquartered in Boston, MA, that operates as a medical technology company. It was founded in 2009 by Andrew Buckler. Blake Richards is currently the CEO of the firm.\nThe company says this about itself: Elucid is a Boston-based medical technology company using uniquely interpretable and validated AI to provide physicians with a cost-effective means to optimize treatment decisions for patients with cardiovascular disease. Advanced clinical insights from Elucid equip physicians with critical information designed to enable precision medicine. Elucid is the first FDA-Cleared and CE-marked non-invasive software to quantify atherosclerotic plaque characteristics compared to histopathology, including Lipid Rich Necrotic Core. The company has published studies for its derivation of fractional flow reserve (FFRct) based on the vasodilative capacity of the vessel wall and estimation of coding and non-coding RNA transcripts (\"Virtual Transcriptomics\"). This unique information informs improved treatment decisions by physicians leading to better patient outcomes, improved quality of care, and reduced healthcare costs. The Elucid software is available for commercial use in the U.S., Europe, and South Korea.